William Blair analyst Tim Lugo reiterated an Outperform ratingt on Zevra Therapeutics, Inc. (NASDAQ: ZVRA).The analyst commented, "Before the markets ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE